We are live on
!
Find out more
BCM
Beryl Capital Management Portfolio holdings
AUM
$110M
1-Year Est. Return
317.92%
This Fund
S&P 500
This Quarter
Est. Return
+4.82%
1 Year Est. Return
+317.92%
3 Year Est. Return
+5,124.04%
5 Year Est. Return
+10,319.28%
10 Year Est. Return
–
AUM
$1.12B
AUM Growth
+$338M
(+43%)
Cap. Flow
+$323M
Cap. Flow
% of AUM
28.79%
Top 10 Holdings %
Top 10 Hldgs %
29.87%
Holding
310
New
103
Increased
31
Reduced
24
Closed
120
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$95M |
| 2 |
PFPT
Proofpoint, Inc.
PFPT
|
+$49.4M |
| 3 |
JWSM
Jaws Mustang Acquisition Corp.
JWSM
|
+$36M |
| 4 |
TLND
Talend S.A. American Depositary Shares
TLND
|
+$32.5M |
| 5 |
SRNG
Soaring Eagle Acquisition Corp. Class A Ordinary Share
SRNG
|
+$22.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PRSP
Perspecta Inc. Common Stock
PRSP
|
+$38.4M |
| 2 |
MIK
Michaels Stores, Inc
MIK
|
+$35M |
| 3 |
PS
Pluralsight, Inc. Class A Common Stock
PS
|
+$32.3M |
| 4 |
HMSY
HMS Holdings Corp.
HMSY
|
+$27.7M |
| 5 |
SLAMU
Slam Corp. Unit
SLAMU
|
+$19.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 42.39% |
| 2 | Technology | 13% |
| 3 | Healthcare | 12.3% |
| 4 | Industrials | 8.46% |
| 5 | Consumer Discretionary | 5.5% |
Similar funds
BCM
NMC
NA
MCM
OWA
PXPO
FA
SCP
Beryl Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Beryl Capital Management held 310 positions worth $1.12B, up 43% from $783M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Beryl Capital Management deployed $323M of net new capital in Q2 2021, opening 103 new positions and adding to 31 existing holdings. Its largest new stake was Alexion Pharmaceuticals: 553,245 shares worth $102M.
By sector, the portfolio is most concentrated in Financials at 42% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was GPGI Inc, an estimated $3.7M trimmed.
- Beryl Capital Management's largest Q2 2021 buy was Alexion Pharmaceuticals: 553,245 shares worth $102M.
- Beryl Capital Management added most to Doma Holdings, Inc. in Q2 2021, an estimated $17.9M increase.
- Beryl Capital Management's biggest Q2 2021 reduction was GPGI Inc, cutting an estimated $3.7M.
- Beryl Capital Management fully exited Perspecta Inc. Common Stock in Q2 2021, selling an estimated $38.4M.
- Beryl Capital Management's ten largest holdings make up 30% of its $1.12B portfolio in Q2 2021.
- Beryl Capital Management opened 103 new positions and closed 120 in Q2 2021.
- Beryl Capital Management's portfolio value rose 43% quarter-over-quarter to $1.12B.
Based on Beryl Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.